Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2024 Filed Nov 25, 2024 23:07 UTC |
SANSONE GUY PDirector
|
GrantCommon Stock | 2,200 | $57.10 | $125,620.00 |
DisclosureSEC source: 0001127602-24-028009 · form4.xml · nonDerivative · entry 1 SANSONE GUY P · CIK 0001301446 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,360.355 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:09 UTC |
Shulman Douglas H.Director
|
GrantCommon Stock | 2,200 | $57.10 | $125,620.00 |
DisclosureSEC source: 0001127602-24-028010 · form4.xml · nonDerivative · entry 1 Shulman Douglas H. · CIK 0001726926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,200 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:10 UTC |
ROBBINS LARRYDirector
|
GrantDeferred Stock Units · Derivative | 2,933.4501 | $57.10 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-24-028011 · form4.xml · derivative · entry 3 ROBBINS LARRY · CIK 0001228603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,933.4501 Underlying: Common Stock · 2,933.4501 shares Expires not disclosed F6 · shares: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the 2017 Incentive Compensation Plan. F7 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. F7 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person. Read SEC document |
| October 23, 2024 Filed Oct 14, 2025 23:08 UTC |
CAPOZZI HEIDI BEVP and Chief People Officer
|
PurchaseCommon Stock | 35 | $56.85 | $1,989.75 |
DisclosureSEC source: 0000064803-25-000031 · form4.xml · nonDerivative · entry 3 CAPOZZI HEIDI B · CIK 0001661608 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 85 F1 · kind: Shares purchased by a broker exercising discretion for a managed account in the name of a trust for the benefit of the Reporting Person's spouse that were not previously reported due to an error on the part of the broker. Read SEC document |
| October 02, 2024 Filed Oct 14, 2025 23:08 UTC |
CAPOZZI HEIDI BEVP and Chief People Officer
|
PurchaseCommon Stock | 10 | $62.24 | $622.40 |
DisclosureSEC source: 0000064803-25-000031 · form4.xml · nonDerivative · entry 2 CAPOZZI HEIDI B · CIK 0001661608 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 50 F1 · kind: Shares purchased by a broker exercising discretion for a managed account in the name of a trust for the benefit of the Reporting Person's spouse that were not previously reported due to an error on the part of the broker. Read SEC document |
| September 09, 2024 Filed Oct 14, 2025 23:08 UTC |
CAPOZZI HEIDI BEVP and Chief People Officer
|
PurchaseCommon Stock | 35 | $56.47 | $1,976.45 |
DisclosureSEC source: 0000064803-25-000031 · form4.xml · nonDerivative · entry 1 CAPOZZI HEIDI B · CIK 0001661608 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 40 F1 · kind: Shares purchased by a broker exercising discretion for a managed account in the name of a trust for the benefit of the Reporting Person's spouse that were not previously reported due to an error on the part of the broker. Read SEC document |
| August 31, 2024 Filed Sep 3, 2024 21:47 UTC |
Mandadi TilakEVP, Chief Technology Officer
|
Tax withholdingCommon Stock | 13,097 | $57.24 | $749,672.28 |
DisclosureSEC source: 0001127602-24-023352 · form4.xml · nonDerivative · entry 1 Mandadi Tilak · CIK 0001872827 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,414 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:32 UTC |
AGUIRRE FERNANDODirector
|
GrantCommon Stock | 2,347 | $57.52 | $134,999.44 |
DisclosureSEC source: 0001127602-24-015894 · form4.xml · nonDerivative · entry 1 AGUIRRE FERNANDO · CIK 0001224983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,523 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:33 UTC |
Balser Jeffrey R.Director
|
GrantCommon Stock | 2,184 | $57.52 | $125,623.68 |
DisclosureSEC source: 0001127602-24-015895 · form4.xml · nonDerivative · entry 1 Balser Jeffrey R. · CIK 0001751633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,277 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:35 UTC |
BROWN C DAVID IIDirector
|
GrantCommon Stock | 2,314 | $57.52 | $133,101.28 |
DisclosureSEC source: 0001127602-24-015896 · form4.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,434 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:36 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 2,184.0229 | $57.52 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-24-015897 · form4.xml · derivative · entry 2 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,994.3033 Underlying: Common Stock · 2,184.0229 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:37 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 2,314 | $57.52 | $133,101.28 |
DisclosureSEC source: 0001127602-24-015898 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,838 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:37 UTC |
FARAH ROGER NDirector
|
GrantShare Credits · Derivative | 5,302.5035 | $57.52 Strike: $0.00 | $305,000.00 |
DisclosureSEC source: 0001127602-24-015899 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,561.3323 Underlying: Common Stock · 5,302.5035 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:38 UTC |
Finucane Anne A.Director
|
GrantShare Credits · Derivative | 2,184.0229 | $57.52 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-24-015900 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,747.6598 Underlying: Common Stock · 2,184.0229 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:39 UTC |
KIRBY J SCOTTDirector
|
GrantCommon Stock | 2,912 | $57.52 | $167,498.24 |
DisclosureSEC source: 0001127602-24-015901 · form4.xml · nonDerivative · entry 1 KIRBY J SCOTT · CIK 0001249555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,633 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:40 UTC |
Mahoney Michael FDirector
|
GrantCommon Stock | 2,184 | $57.52 | $125,623.68 |
DisclosureSEC source: 0001127602-24-015902 · form4.xml · nonDerivative · entry 1 Mahoney Michael F · CIK 0001533022 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,001 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:41 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 2,314 | $57.52 | $133,101.28 |
DisclosureSEC source: 0001127602-24-015903 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,314 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:42 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 2,912.0306 | $57.52 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-24-015904 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,017.4328 Underlying: Common Stock · 2,912.0306 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:30 UTC |
Mahoney Michael FDirector
|
PurchaseCommon Stock (By Trust) | 9,181 | $54.49 | $500,293.81 |
DisclosureSEC source: 0001127602-24-013995 · form4.xml · nonDerivative · entry 1 Mahoney Michael F · CIK 0001533022 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,356 F1 · security: Consists of shares held in trusts for the benefit of the reporting person or the reporting person and his spouse. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:31 UTC |
LUDWIG EDWARD JDirector
|
PurchaseCommon Stock | 1,000 | $53.88 | $53,879.00 |
DisclosureSEC source: 0001127602-24-013997 · form4.xml · nonDerivative · entry 1 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,630 Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:47 UTC |
Lynch Karen SDirector · President and CEO
|
GrantStock Option · Derivative | 188,087 | $79.56 Strike: $79.56 | $14,964,201.72 |
DisclosureSEC source: 0001127602-24-012256 · form4.xml · derivative · entry 3 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,087 Underlying: Common Stock · 188,087 shares Expires 2034-04-01 F3 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:47 UTC |
Lynch Karen SDirector · President and CEO
|
Tax withholdingCommon Stock | 61,953 | $79.56 | $4,928,980.68 |
DisclosureSEC source: 0001127602-24-012256 · form4.xml · nonDerivative · entry 2 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,687 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:47 UTC |
Lynch Karen SDirector · President and CEO
|
GrantCommon Stock (Restricted) | 45,248 | $79.56 | $3,599,930.88 |
DisclosureSEC source: 0001127602-24-012256 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,248 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:49 UTC |
Mandadi TilakEVP, Chief Technology Officer
|
GrantStock Option · Derivative | 67,920 | $79.56 Strike: $79.56 | $5,403,715.20 |
DisclosureSEC source: 0001127602-24-012257 · form4.xml · derivative · entry 2 Mandadi Tilak · CIK 0001872827 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,920 Underlying: Common Stock · 67,920 shares Expires 2034-04-01 F2 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:49 UTC |
Mandadi TilakEVP, Chief Technology Officer
|
GrantCommon Stock (RSU) | 16,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012257 · form4.xml · nonDerivative · entry 1 Mandadi Tilak · CIK 0001872827 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,904 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC |
Shah Prem SEVP and Pres-Pharm, Consumer W
|
GrantStock Option · Derivative | 62,695 | $79.56 Strike: $79.56 | $4,988,014.20 |
DisclosureSEC source: 0001127602-24-012258 · form4.xml · derivative · entry 4 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,695 Underlying: Common Stock · 62,695 shares Expires 2034-04-01 F4 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC |
Shah Prem SEVP and Pres-Pharm, Consumer W
|
GrantCommon Stock (Restricted) | 15,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012258 · form4.xml · nonDerivative · entry 3 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,057 F3 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC |
Shah Prem SEVP and Pres-Pharm, Consumer W
|
Tax withholdingCommon Stock | 5,239 | $79.56 | $416,814.84 |
DisclosureSEC source: 0001127602-24-012258 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,034.463 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC |
Shah Prem SEVP and Pres-Pharm, Consumer W
|
Tax withholdingCommon Stock | 2,653 | $79.56 | $211,072.68 |
DisclosureSEC source: 0001127602-24-012258 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,273.463 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC |
COWHEY THOMAS F.EVP and CFO
|
GrantStock Option · Derivative | 62,695 | $79.56 Strike: $79.56 | $4,988,014.20 |
DisclosureSEC source: 0001127602-24-012259 · form4.xml · derivative · entry 3 COWHEY THOMAS F. · CIK 0001735242 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,695 Underlying: Common Stock · 62,695 shares Expires 2034-04-01 F3 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC |
COWHEY THOMAS F.EVP and CFO
|
GrantCommon Stock (Restricted) | 15,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012259 · form4.xml · nonDerivative · entry 2 COWHEY THOMAS F. · CIK 0001735242 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,995 F2 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC |
COWHEY THOMAS F.EVP and CFO
|
Tax withholdingCommon Stock | 1,719 | $79.56 | $136,763.64 |
DisclosureSEC source: 0001127602-24-012259 · form4.xml · nonDerivative · entry 1 COWHEY THOMAS F. · CIK 0001735242 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,642 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:54 UTC |
Khichi Samrat S.EVP, CPO and General Counsel
|
GrantStock Option · Derivative | 52,246 | $79.56 Strike: $79.56 | $4,156,691.76 |
DisclosureSEC source: 0001127602-24-012261 · form4.xml · derivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,246 Underlying: Common Stock · 52,246 shares Expires 2034-04-01 F2 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:54 UTC |
Khichi Samrat S.EVP, CPO and General Counsel
|
GrantCommon Stock (Restricted) | 12,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012261 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,490 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:58 UTC |
Kane Brian AEVP/President, Aetna
|
GrantStock Option · Derivative | 52,246 | $79.56 Strike: $79.56 | $4,156,691.76 |
DisclosureSEC source: 0001127602-24-012264 · form4.xml · derivative · entry 2 Kane Brian A · CIK 0001609525 · EVP/President, Aetna 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,246 Underlying: Common Stock · 52,246 shares Expires 2034-04-01 F2 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:58 UTC |
Kane Brian AEVP/President, Aetna
|
GrantCommon Stock (Restricted) | 12,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012264 · form4.xml · nonDerivative · entry 1 Kane Brian A · CIK 0001609525 · EVP/President, Aetna 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,569 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Joyner J. DavidEVP&President-PharmacyServices
|
GrantCommon Stock (Restricted) | 28,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012266 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP&President-PharmacyServices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,241 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
GrantStock Option · Derivative | 39,184 | $79.56 Strike: $79.56 | $3,117,479.04 |
DisclosureSEC source: 0001127602-24-012271 · form4.xml · derivative · entry 3 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,184 Underlying: Common Stock · 39,184 shares Expires 2034-04-01 F3 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
GrantCommon Stock (Restricted) | 9,426 | $79.56 | $749,932.56 |
DisclosureSEC source: 0001127602-24-012271 · form4.xml · nonDerivative · entry 2 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,426 F2 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
Tax withholdingCommon Stock | 7,630 | $79.56 | $607,042.80 |
DisclosureSEC source: 0001127602-24-012271 · form4.xml · nonDerivative · entry 1 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,553 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
GrantStock Option · Derivative | 28,735 | $79.56 Strike: $79.56 | $2,286,156.60 |
DisclosureSEC source: 0001127602-24-012274 · form4.xml · derivative · entry 4 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,735 Underlying: Common Stock · 28,735 shares Expires 2034-04-01 F4 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
GrantCommon Stock (Restricted) | 6,913 | $79.56 | $549,998.28 |
DisclosureSEC source: 0001127602-24-012274 · form4.xml · nonDerivative · entry 3 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,666 F3 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 825 | $79.56 | $65,637.00 |
DisclosureSEC source: 0001127602-24-012274 · form4.xml · nonDerivative · entry 2 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,211.9847 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 1,473 | $79.56 | $117,191.88 |
DisclosureSEC source: 0001127602-24-012274 · form4.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,036.9847 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (Restricted) | 10,683 | $79.56 | $849,939.48 |
DisclosureSEC source: 0001127602-24-012275 · form4.xml · nonDerivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,109 F3 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 1,112 | $79.56 | $88,470.72 |
DisclosureSEC source: 0001127602-24-012275 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,480 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:03 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 1,892 | $79.56 | $150,527.52 |
DisclosureSEC source: 0001127602-24-012275 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,592 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:18 UTC |
Khichi Samrat S.EVP, CPO and General Counsel
|
Tax withholdingCommon Stock | 6,210 | $75.19 | $466,929.90 |
DisclosureSEC source: 0001127602-24-007927 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,750 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:20 UTC |
COWHEY THOMAS F.SVP, Interim CFO
|
Tax withholdingCommon Stock | 5,641 | $75.19 | $424,146.79 |
DisclosureSEC source: 0001127602-24-007928 · form4.xml · nonDerivative · entry 1 COWHEY THOMAS F. · CIK 0001735242 · SVP, Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,631 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:21 UTC |
Joyner J. DavidEVP&President-PharmacyServices
|
Tax withholdingCommon Stock | 1,970 | $75.19 | $148,124.30 |
DisclosureSEC source: 0001127602-24-007929 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP&President-PharmacyServices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,681 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.